Welcome to the Oncomine Blog

UAB Study Evaluates the Oncomine Myeloid Research Assay GX on the Genexus System

06/07/2021

Performance of the Oncomine Myeloid Research Assay GX

Craig Mackinnon, MD, PhD, Director of Genomic Diagnostics and Bioinformatics and Professor of the Department of Pathology, and his team at the University of Alabama, Birmingham (UAB) conducted a..

Let’s Do It Ourselves - A global expert consensus ...

Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have ...

A Comprehensive Answer for Cancer: Is ...

What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of ...

Biomarker Tests for Precision Oncology: DIY or ...

Cancer patient management of is increasingly driven by biomarker assays – but how should we manage ...

Evaluating the Oncomine Myeloid Assay GX for ...

Dr. Yi Ding of Geisinger Medical Laboratories recently presented at the 2020 Association of ...

Is Comprehensive Genomic Profiling the Right ...

What is comprehensive genomic profiling? Comprehensive genomic profiling, or CGP, is the ...

The Importance of Detecting Copy Number Variants ...

Structural variants in the cancer genome Gene amplification (copy number gain) and deletion (copy ...

Breakthrough Device Designation for Oncomine Dx ...

Philip Scard knew immediately and intimately that the June 15 news release from Thermo Fisher ...

The Impact of NGS in Hematology-Oncology

In aggressive forms of cancer such as acute myeloid leukemia (AML), accurate diagnosis is needed as ...

The OncomineWorld Experience from Behind the ...

BACKGROUND:  There is little to no point in saying that we are all living in an unprecedented time, ...